Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Releases Earnings Results

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENSGet Free Report) issued its quarterly earnings data on Monday. The company reported ($0.47) earnings per share for the quarter, FiscalAI reports. The business had revenue of $14.26 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 133.22% and a negative net margin of 217.71%.

Senseonics Holdings, Inc. Common Stock Trading Up 0.7%

SENS stock traded up $0.06 during mid-day trading on Monday, reaching $8.33. The company’s stock had a trading volume of 476,143 shares, compared to its average volume of 459,974. Senseonics Holdings, Inc. Common Stock has a 12 month low of $5.25 and a 12 month high of $19.20. The company has a debt-to-equity ratio of 0.45, a quick ratio of 5.93 and a current ratio of 6.23. The company has a market cap of $340.36 million, a P/E ratio of -5.11 and a beta of 0.90.

Wall Street Analyst Weigh In

Separately, Weiss Ratings initiated coverage on Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They issued a “sell (d-)” rating for the company. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

View Our Latest Analysis on Senseonics Holdings, Inc. Common Stock

About Senseonics Holdings, Inc. Common Stock

(Get Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

Featured Stories

Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.